MyFinsight
Home
Blog
About
Back
Cash Flow
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc. (APVO)
source: myfinsight.com
Proceeds from issuance of
common stock, net of...
$872K
Net cash provided by
financing activities
$871K
Canceled cashflow
$1K
Increase (decrease) in
cash and cash...
-$7,094K
Canceled cashflow
$871K
Non-cash lease expense
$271K
Stock-based compensation
$57K
Depreciation and
amortization
$35K
Accounts payable
$13K
Prepaid expenses and
other current assets
-$3K
Payments in lieu of
fractional shares
$1K
Net cash used in
operating activities
-$7,965K
Canceled cashflow
$379K
Net loss
-$6,697K
Accrued expenses and
other current...
-$1,303K
Operating lease liability
-$344K
Back